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Abstract
The predilection of Plasmodium vivax (P. vivax) for reticulocytes is a major obstacle for its establishment in a long-term
culture system, as this requires a continuous supply of large quantities of reticulocytes, representing only 1–2% of
circulating red blood cells. We here compared the production of reticulocytes using an established in vitro culture system
from three different sources of hematopoietic stem/progenitor cells (HSPC), i.e. umbilical cord blood (UCB), bone marrow
(BM) and adult peripheral blood (PB). Compared to CD34+-enriched populations of PB and BM, CD34+-enriched populations
of UCB produced the highest amount of reticulocytes that could be invaded by P. vivax. In addition, when CD34+-enriched
cells were first expanded, a further extensive increase in reticulocytes was seen for UCB, to a lesser degree BM but not PB. As
invasion by P. vivax was significantly better in reticulocytes generated in vitro, we also suggest that P. vivax may have a
preference for invading immature reticulocytes, which should be confirmed in future studies.
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Introduction
Plasmodium vivax (P. vivax) is the most widespread malaria
parasite outside sub-Saharan Africa, and accounts for 80 to 300
million of malaria cases per year [1]. The predilection of P. vivax
for reticulocytes is a major obstacle for the establishment of a long-
term P. vivax culture system [2,3]. As reticulocytes represent only
1–2% of the circulating red blood cells (RBCs) with a half-life of 2
days (including 1 day in the peripheral blood), collecting sufficient
reticulocytes to maintain a P. vivax culture is a challenge [3].
It has been previously shown that reticulocytes can be obtained
by concentrating adult peripheral blood (PB) or umbilical cord
blood (UCB) using either a 70% percoll solution [4] or a plasma
autologous ultra-centrifugation [5]. One study suggested that P.
vivax could be maintained in culture for up to 85 days with
reticulocytes concentrated from umbilical blood cord (UCB) [6];
however, parasites did not develop beyond one schizogony cycle
and parasite densities were very low [7]. In addition, it is possible
to culture hematopoietic stem/progenitor cells (HSPC)/CD34+
cells to induce erythroid differentiation and consequently produce
reticulocytes in vitro [8]. Reticulocytes generated from CD34+
cells from both bone marrow (BM) and peripheral blood
mononuclear cells (PBMC) have been previously used for culturing
P. vivax; but the authors did not provide data regarding the
efficiency of invasion and the development of the parasites in vitro
[9].
In this report, we compared different sources of hematopoietic
stem/progenitor cells (HPSC), namely UCB, BM and peripheral
blood, for their capacity to produce reticulocytes that allow
invasion by P. vivax.
Materials and Methods
HSPCs expansion and reticulocytes differentiation
CD34+ cell isolation. The differentiation of HSPC into
reticulocytes was done according to a previously described
protocol [10]. UCB was obtained from the Belgian Cord Blood
Bank at the Gasthuisberg Hospital Leuven, BM samples were
obtained from volunteer donors; and human peripheral blood
from the Antwerp Red Cross. Mononuclear cells from peripheral
blood (PBMC), UCB and BM were isolated on a Ficoll gradient
(GE Healthcare), by 30 minutes centrifugation at 400 g. The
mononuclear cells were collected and washed twice with PBS.
CD34+ enriched HSPCs were isolated using Magnetic Assorting
Cell Sorting (MACS, Biotenyl Biotech). HSPC cell purity after
MACS selection was assessed by FACS analysis, using CD34 and
CD45 antibodies (eBioscience).
Reticulocytes differentiation
CD34+-enriched cells were dispensed in a 6-well plate with
IMDM medium (Gibco) supplemented with L-glutamine (4 M,
Sigma), penicillin-streptomycin (1%, Invitrogen), folic acid (10 mg/
mL, Sigma), inositol (40 mg/mL, Sigma), transferrin (120 mg/mL,
Sigma), monothioglycerol (1.6 1024 M, Sigma), insulin (10 mg/
mL, Sigma) and 10% human plasma. During the first 8 days, the
medium was supplemented with the following factors: hydrocor-
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tisone (HDS, 1026 M, Sigma), interleukin-3 (IL-3, 5 ng/mL,
R&D system), stem cell factor (SCF, 100 ng/mL, Bioke) and
erythropoietin (EPO, 3 IU/mL, R&D system) and placed at 37uC
in a 5% CO2 incubator. The initial volume of medium was 4 mL
and after 4 days, an extra 3 mL was added. After 8 days, the cells
were centrifuged for 5 minutes at 300 g, fresh IMDM medium
supplemented with EPO (3 IU/mL) was added, and the cells were
transferred in a 25 cm2 flask. On day 11, the medium was changed
and complete medium was added without EPO. Afterwards,
medium was refreshed every 3 days and 10% heat inactivated
human serum was added to protect the viability of the cells.
For CD34+ cell expansion, CD34+ enriched cells were
dispensed in a 6-well plate with 4 mL Serum-free expansion
medium (SFEM, Sigma) with SCF (50 ng/mL), thrombopoietin
(TPO, 50 ng/mL, R&D system), FMS-like tyrosine kinase 3
(FLT3, 50 ng/mL, R&D system) and IL-6 (50 ng/mL, R&D
system) for 5 days at 37uC, and 5% CO2. On day 5, the cells were
counted, and transferred into a new 6-well plate to induce the
reticulocyte differentiation (using the protocol described above).
Reticulocyte concentration
Reticulocytes were enriched from UCB or PB by loading on a
70% isotonic percoll cushion which was spun for 15 minutes at
400 g. After two washes with PBS, reticulocytes were counted as
described below.
Reticulocyte count
Cells were spun at 300 g for 5 minutes and re-suspended in
50 mL of PBS; 50 mL of Cresyl blue (Roche) diluted 1:1000 was
added and cells were incubated at room temperature for
30 minutes. After a cytospin centrifugation (3 minutes at
700 rpm), the cells were fixed with methanol, and stained for
10 minutes with Giemsa (Sigma). The slides were then examined
by microscopy (immersion objective, 6306 magnification), and
reticulocytes were counted against a minimum of 500 RBCs and
the density per 100 RBCs was computed. A reticulocyte was
morphologically defined as an enucleated cell with at least 3 dots
of cresyl blue RNA.
Plasmodium vivax invasion assays
Cryopreserved P. vivax isolates [11] from infected patients were
provided by the Shoklo Malaria Research Unit (SMRU, Mae Sot,
Thailand). The samples were thawed with NaCl solutions and
cultured for 36 to 40 hours with McCoy’s medium (Gibco)
supplemented with glucose (2%) and 20% heat inactivated human
serum. P. vivax mature forms were concentrated on a 45% percoll
after a 5 minutes treatment with 0.05% trypsin. After 15 minutes
of centrifugation at 1600 g, cells above the 45% percoll were
collected and washed twice before checking the quality of the
concentration. If more than 90% of the cells contained parasites,
they were mixed with our previously differentiated and cryopre-
served reticulocytes (chosen to contain the same percentage of
reticulocytes for all the conditions tested) in a 96-well plate and the
initial parasite density was adjusted on a 1:6 ratio (final volume
100 mL, hematocrit 2–5%). Cells were checked at 24 hours post-
invasion by doing a cytospin slide stained with Giemsa. The
parasite densities were computed after examining a minimum of
500 RBCs.
Data analysis
Data were entered and analyzed with STATA12 (StataCorp,
Texas). Reticulocytes were counted after 14 days of differentiation
and the mean6SD calculated for each source of HSPC. The
Kruskall-Wallis test was used to compare population means.
Means and standard deviations were calculated to summarize
HSPC expansion rates.
Ethics statement
P. vivax samples collection was approved by the ethics
committees of the faculty of tropical medicine, Mahidol Univer-
sity, Bangkok, Thailand (number MUTM-2008-15) and the
University of Oxford, Centre for Clinical Vaccinology and
Tropical Medicine, United Kingdom (Ethics approval number:
OXTREC 027-025). UCB were collected from the cord blood
bank at the Gasthuisberg Hospital, Leuven, Belgium (Ethics
approval number ML6620). Bone marrow samples were taken
from voluntary donors at the Gasthuisberg hospital, Leuven,
Belgium (Ethics approval number B322201112107). Adult pe-
ripheral blood samples were bought from the Antwerp Red Cross
blood bank.
A written inform consent was signed by each donor.
Results
Reticulocyte production from BM, PB and UCB CD34+-
enriched cell populations
Reticulocyte differentiation was successfully induced from
magnetically sorted CD34+-enriched populations from UCB,
PBMC and BM in three independent experiments (n = 3). The
enrichment for CD34+ cells in the sorted populations was 55%
(SD66) for UCB, 35% (SD68) for BM and 16% (SD66), for
PBMC (3 independent experiments) as determined by FACS. The
peak of enucleation occurred after 14 days of differentiation,
Table 1. Hematopoietic stem progenitor cells (HSPC) expansion and reticulocyte differentiation for three different sources HSPCs
(6 independent experiments were carried out for each HSPC source).
HSPC sources
Mean proportion (%) of reticulocytes
at D14 (± SD) (n=6) Cell number mean fold increase (± SD) (n =3)
After 5 days of expansion After 7 days of differentiation
UCB 18.361.3 11.562.3 33.562.4
BM 20.561.5 3.160.3 8.660.5
PBMC 3266 1.360.2 3.460.2
Results show the mean proportions of reticulocytes observed at the peak of enucleation after 14 days of culture, as well as the increase in total cell number after 5 days
of expansion and 7 days of differentiation (3 independent experiments). After 5 days of expansion, the number of cells was counted and divided by the initial number of
plated MACS/CD34+ cells, while after 7 days of HSPC differentiation, the cell count was compared to the number of cells not previously expanded, results are expressed
in mean fold increase (6 SD).
doi:10.1371/journal.pone.0112496.t001
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regardless of the source. The enucleation of erythroid cells from
PBMC (mean = 32, SD66) was significantly higher (p = 0.002)
than that of UCB (18%, SD61.3 and BM (21%, SD61.5)
(Table 1, 6 independent experiments).
Reticulocyte production from ex vivo expanded BM, PB
and UCB CD34-enriched cell populations
We next tested if larger numbers of reticulocytes could be
obtained from ex vivo expanded CD34+-enriched cell populations.
After 5 days of expansion in serum-free medium with TPO and
SCF, the total cell populations increased .10-fold in cultures
initiated with UCB/CD34+-enriched cells, 3-fold for BM/CD34+-
enriched cells while for PBMC no expansion was observed
(Table 1, 3 independent experiments). FACS analysis demonstrat-
ed an increase in the CD34+/CD45+ population between Day 0
and Day 5 for all three cell sources: from 55% to 70% (SD62) for
UCB, 35% to 55% (SD65) for BM, and 16% to 29% (SD616) for
PBMC (n = 3 for CB and BM, n = 2 for PBMC)(Figure 1).
Following expansion, a similar number of cells (irrespective of
the CD34+ content or expansion) were cultured under reticulocyte
differentiation conditions. After 7 days of erythroid differentiation,
the total number of cells, previously subject to an expansion step,
was 3 times higher compared to CD34+ cells that were
immediately induced to differentiate. After 14 days of differenti-
ation, expanded cells expressed high levels of CD235a and CD71
receptors, regardless of cell source (respectively 87.4% for UCB,
81.7% for BM and 70.6% for PB; Figure 2). Compared to
unexpanded cells, the proportion of reticulocytes obtained at day
14 from in vitro expanded CD34+ cells was 5 to 10-fold higher.
P. vivax invasion
P. vivax parasites invaded reticulocytes derived from CD34+
cells or directly obtained from enriched blood (PB or UCB;
Figure 3). The mean invasion rates for the different sources of
HSPC sources were 3.05%, 3.05% and 3.15% respectively for
UCB, BM and PB (n = 4). The means for UCB-concentrated
reticulocytes (n = 4) and PB-concentrated reticulocytes (n = 3) were
respectively 1.4% and 0.2%.
When using the same P. vivax isolate, the invasion rate between
different HSPC sources did not differ for all of the 4 P. vivax
isolates tested (Figure 4a); however, the invasion rate observed
varied for each of the P. vivax isolates used. When we compared
two different P. vivax isolates using the same HSPC-derived
reticulocytes, the invasion rate varied significantly by isolate
(Figure 4b; PV1 and PV2, p,0.001). After 3 days of culture, only
few rings (parasite density ,0.05%) could be observed and none
survived longer than 72 hours, regardless of the HSPC source.
Interestingly, the invasion rate of P. vivax in HSPC-derived
reticulocytes appeared to be higher when compared with
reticulocytes isolated directly from PB. For the same P. vivax
isolate, the parasite density 24 hours post-invasion in UCB/
HSPC-derived reticulocytes was up to 9-fold higher than in UCB-
concentrated reticulocytes (1.8% versus 0.2%, respectively), and
18-fold higher than adult PB-concentrated reticulocytes (2.1%
versus 0.1% respectively). Parasite densities were not significantly
different between HSPC-derived reticulocytes (5%), UCB-concen-
trated reticulocytes (4.6% p = 0.056) and PB-concentrated reticu-
locytes (3.5% p = 0.06) when the reticulocyte percentage was 20%
for HSPC-derived reticulocytes and respectively 60% and 70% for
reticulocytes concentrated from PB and UCB.
Discussion
In this study, we compare for the first time different source of
HSPC to generate reticulocytes suitable for P. vivax studies. We
could demonstrate that compared with CD34+-enriched popula-
tions from PB and BM, CD34+-enriched populations from UCB
Figure 1. FACS analyses of the CD34+/CD45+ cells from UCB, PBMNC and BM, after isolation (Day 0) and following 5 days of
expansion. The Q2 gate represents the population double positive for CD34 (APC) and CD45 (PE).
doi:10.1371/journal.pone.0112496.g001
Figure 2. FACS analyses of the CD235a+/CD71+ cells from UCB, PBMNC and BM, after 5 days of expansion and 14 days of
differentiation. The Q2 gate represents the population positive for CD235a (Per-CP-Cy5-5) and CD71 (PE).
doi:10.1371/journal.pone.0112496.g002
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produced the highest number of reticulocytes that can be invaded
by P. vivax. Second, when CD34+-enriched cells were first
expanded, a further extensive increase in reticulocytes was
generated from UCB, to a lesser degree BM but not PB.
The number of reticulocytes derived from UCB CD34+
enriched cell populations could be substantially increased when
the CD34+ cells were first expanded for 5 days. Noteworthy, in our
experiments PB/HSPC cells showed a limited increase of the
population after 5 days of expansion compared to UCB/HSPC
and BM/HSPC. This is likely due to the low frequency of CD34+
cell in non-mobilized PBMC [12] and the more mature fate of
HSPC in PB or BM compared to cells from UCB [13].
Reticulocytes derived from magnetically sorted CD34+ cells
from either PBMC, BM or UCB could be invaded by P. vivax
with similar efficiencies, while invasion was significantly influenced
by the type of P. vivax isolate. Despite successful invasion, none of
the produced reticulocyte population could support the full
development and long-term culture of P. vivax. Reticulocytes
generated in this study were more permissive for P. vivax invasion
compared with the study published by Panichakul et al [6], who
observed only 0.0015% of invasion, mainly due to a very low
percentage of reticulocytes (0.5%); or Furuya et al [14] who used
frozen erythroblast derived from UCB/HSPC (0.8% parasitemia).
The 3.5% parasitemia rate observed in our study are in line with
the invasion rate observed by Borlon et al (2.1%) [11] and Russell
et al (3.7%) [4], both using reticulocyte-enriched UCB (percentage
of reticulocytes greater than 50%).
Our observations might also suggest a preference of P. vivax for
more immature reticulocytes as we observed a higher invasion rate
of reticulocytes derived from any HSPC source compared to those
concentrated from either UCB or PB. The higher invasion rate in
HSPC derived reticulocytes concentrated from UCB compared to
those from PB could be explained by the distribution of their
reticulocytes populations. Indeed, Paterakis et al [15] classified
reticulocytes according to their RNA content by FACS analysis
and divided them into 3 categories, i.e. immature reticulocytes
(high amount of RNA), median, and old reticulocytes (medium
and low amount of RNA, respectively). They found that among
the reticulocyte population, UCB contains more immature
reticulocytes (13.6%) than adult peripheral blood (1%). Further-
more, HSPC-derived reticulocytes were collected at the peak of
enucleation, i.e. when they were at an immature stage of
development. This provides additional evidence for preference of
P. vivax for immature reticulocytes and should be further
investigated.
When reticulocyte-enriched blood from UCB and PB was used
at 3-fold higher reticulocyte concentrations (70% and 60%,
respectively), the invasion rates became similar to that obtained
with HSPC-derived reticulocytes (20% for HSPC). This is in line
with a recently published report by Martı´n-Jaular et al [16]
wherein the authors observed a predominant invasion of
CD71high-expression cells (CD71 being a marker of reticulocyte
maturation, as their expression decrease while the reticulocyte
maturate to the RBC stage) by P. yoelii (a mouse Plasmodium
species also invading preferentially reticulocytes).
Our preliminary observations need further in-depth investiga-
tion to provide new insights into the invasion mechanisms of P.
vivax, and more specifically on the critical stage-specific receptors.
If confirmed, this hypothesis would justify the use of reticulocytes
derived from HSPC instead of reticulocyte-enriched blood as
target cells for the establishment of continuous P. vivax cultures.
In conclusion, our results demonstrate that it is possible to
produce large amounts of immature reticulocytes that can be
efficiently invaded by P. vivax. The ability to derive reticulocytes
from UCB/HSPCs in in larger quantities than from PB or BM/
HSPCs without loosing the permissiveness to P. vivax make this
source of HSPC as more suitable and likely to develop into a
standardized and continuous source of reticulocytes for the long-
term culture of P. vivax.
The possibility to efficiently expand the CD34+ population to
generate more reticulocytes coupled with the possibility to
cryopreserve those HSPC-derived reticulocytes [7] opens also
new perspectives to create stocks of reticulocytes to use as target
cells for the establishment of an in vitro culture of P. vivax.
Figure 3. Cytopsin of the P. vivax culture 24 h post-invasion for
different sources of reticulocytes. A) UCB/HSPC, B) BM/HSPC, C)
PB/HSPC, D) reticulocytes-enriched UCB and E) reticulocytes-enriched
PB. The left panels represent pictures with a 636magnification and the
corresponding right panels represent a 1006of the left picture square.
P. vivax infected cells are under arrow.
doi:10.1371/journal.pone.0112496.g003
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